Cell No. : Cell Name
RCB0508 : H-EMC-SS
update : 2023/05/11
|
| Comment | Extraskeletal myxoid chondrosarcoma |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Saotome, Kouichi
|
| Originator |
Saotome, K. & Sibukawa, A.
|
| Year of deposit |
1990
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Race |
Japanese
|
| Gender |
Female
|
| Age at sampling |
77 years
|
| Tissue |
muscle
|
| Disease name |
chondrosarcoma
|
| Metastatic ability |
Yes
|
| Metastatic tissue |
lymph node,lung
|
| Classification |
cancer
|
| Year of origin |
1987
|
| Memo_1 |
Mycoplasma was eliminated with MC-210 by the depositor.
|
|
Lifespan |
infinite
|
| Morphology |
other
|
| Cellosaurus(Expasy) |
CVCL_1238
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Culture medium |
|
MEM ALPHA (or DM-160AU) + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 4 split
|
| SC frequency |
|
Subculture : once/week, Medium Renewal : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma |
|
(-)
|
| Isozyme |
|
LD, NP
|
| Chromosome mode |
|
45-47(50) : 45(5),46(43),47(2)
|
| STR(human) |
|
OK
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
1
|
| User's Publication |
5
|
| User's Publication |
|
18138
Higuchi T, Takeuchi A, Munesue S, Yamamoto N, Hayashi K, Harashima A, Yamamoto Y, Tsuchiya H.
A nonsteroidal anti-inflammatory drug, zaltoprofen, inhibits the growth of extraskeletal chondrosarcoma cells by inducing PPARγ, p21, p27, and p53
Cell Cycle
2023
22(8):939-950
PubMed ID: 36636023
DOI: 10.1080/15384101.2023.2166195
|
|
10779
Goto H, Nishio M, To Y, Oishi T, Miyachi Y, Maehama T, Nishina H, Akiyama H, Mak TW, Makii Y, Saito T, Yasoda A, Tsumaki N, Suzuki A.
Loss of Mob1a/b in mice results in chondrodysplasia due to YAP1/TAZ-TEAD-dependent repression of SOX9.
Development
2018
145:
PubMed ID: 29511023
DOI: 10.1242/dev.159244
|
|
7810
Akiyama K, Tone J, Yamauchi S, Sugahara T, Maruyama M, Kakinuma Y.
Disruption of ion homeostasis by verrucosin and a related compound.
Biosci. Biotechnol. Biochem.
2011
75:1000-2
PubMed ID: 21597167
DOI: 10.1271/bbb.110004
|
|
6475
Osaki M, Osaki M, Yamashita H, Shomori K, Yoshida H, Ito H.
Expression of minichromosome maintenance-2 in human malignant fibrous histiocytomas: Correlations with Ki-67 and P53 expression, and apoptosis.
Int J Mol Med
2002
10(2):161-8
PubMed ID: 12119552
|
|
1902
Shu Qin Liu, Kaoru Saijo, Makoto Kodama, Tadao Ohno
Intelligent matrices for tumor-specific cytotoxic T lymphocytes
Materials Science and Engineering: C
1994
2:61-65
DOI: 10.1016/0928-4931(94)90030-2
|
Back
Top
CELL BANK Website
